Genelux Corporation Common Stock

GNLXNASDAQ • USD
1.87 USD
↗ 0.00 (0.00%)🟢PRE MARKET (AS OF 04:00 AM EST)
🟢Market: OPEN

GNLX is currently priced at $1.87. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, GNLX is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 13, 2026.

Open?$1.87
High?$1.87
Low?$1.87
Prev. Close?$1.87
Volume?0
Avg. Volume?380.8K
Bid / Ask
Bid?$1.54 × 100
Ask?$2.46 × 100
Spread?$0.92
Midpoint?$2.00
Valuation & Ratios
Market Cap?84.6M
Shares Out?45.2M
Float?35.9M
Float %?80.0%
P/E Ratio?N/A
P/B Ratio?5.25
EPS?-$0.79
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Employees
26
Market Cap
84.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2023-01-26
Address
2625 TOWNSGATE ROAD, SUITE 230
WESTLAKE VILLAGE, CA 91361
Phone: 805-267-9889
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
23
Short Sent.?
54
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.18Distress
Confidence?53%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?12.63%High
Short Interest?4.5M
Days to Cover?8.3
Free Float35.9M
Avg Daily Volume544.6K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.39Strong
Quick Ratio?2.39Strong
Cash Ratio?1.15Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
35
5.25FAIR▾
P/S?
Peers
100
S&P
3
10,576.10HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.1CHEAP▾
EV/Sales?
Peers
100
S&P
3
9,428.10HIGH▾
Returns & Efficiency
ROE?
S&P
3
-220.9%WEAK▾
ROA?
S&P
3
-135.8%WEAK▾
Cash Flow & Enterprise
FCF?$-28683000
Enterprise Value?$75.4M
Fundamentals ratios updated end of day